The crystal structure of 5-(2-(4-fluorophenyl)hydrazono)-4-methyl-2-((3-(5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene) hydrazono)-2,5-dihydrothiazole dimethylformamide monosolvate, C30H25FN10S?C3H7NO by Alotaibi, Abdullah A. et al.
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Abstract
C30H25FN10S·C3H7NO, triclinic, P1¯ (no. 2), a= 10.9189(6) Å,
b= 12.3898(7) Å, c= 13.9206(7) Å, α= 199.412(4)°,
β= 110.024(5)°, γ= 105.904(5)°, V = 1631.17(17) Å3, Z= 2,
Rgt(F)=0.0536, wRref(F2)=0.1471, T= 296 K.
CCDC no.: 1989316
The structure is shown in the figure. Table 1 contains
crystallographic data and Table 2 contains the list of
the atoms including atomic coordinates and displacement
parameters.
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Table 1: Data collection and handling.
Crystal: Yellow block
Size: 0.31×0.21×0.07 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 0.15 mm−1
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: 29.9°,>99%
N(hkl)measured, N(hkl)unique, Rint: 28922, 8174, 0.039
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 5125
N(param)refined: 427





(0.83 g, 2.0 mmol), N′-(4-fluorophenyl)-2-oxopropanehydra-
zonoyl chloride (0.43 g, 2.0 mmol) and triethylamine (0.20 g,
2.0 mmol) in anhydrous ethanol (20 mL) were heated under
reflux for 2 h to give the title compound. The solid obtained
on cooling was filtered, washed with cold ethanol, dried and
recrystallized fromdimethylformamide to give yellow crystals
in 78% yield.
Experimental details
All hydrogen atoms were identified in difference Fourier syn-
theses. The electron density indicated disorder in the hydro-
gen atoms of onemethyl group of dimethylformamide and the
methyl group linked to the thiazolyl ring. The ordered methyl
hydrogens and those bonded to sp2 carbon atoms were ideal-
ized during refinement using the options AFIX 33 and AFIX
43, respectively in the SHELXL-2018 program [3]. The SHELX
option AFIX 123 was used for disordered methyl groups. The
U iso values were set to 1.5Ueq(C) for methyl groups hydrogen
atoms and 1.2Ueq(C/N) for the rest.
Comment
1,2,3-Triazoles are important heterocycles due to their
immense pharmacological and biological applications [5–7].
In addition, compounds containing pyrazoles and thiazole
Open Access.© 2020 Abdullah A. Alotaibi et al., published by De Gruyter. This work is licensed under the Creative Commons Attribution 4.0
Public License.
916 | Alotaibi et al.: C30H25FN10S·C3H7NO
Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
C1 −0.0652(2) 1.03548(17) 0.20981(18) 0.0531(5)
C2 0.0136(2) 1.0813(2) 0.31873(19) 0.0632(6)
H2 0.0796 1.0508 0.3533 0.076*
C3 −0.0061(3) 1.1727(2) 0.3763(2) 0.0751(7)
H3 0.0464 1.2043 0.4494 0.090*
C4 −0.1037(3) 1.2152(2) 0.3237(3) 0.0798(8)
C5 −0.1813(3) 1.1727(2) 0.2174(3) 0.0819(8)
H5 −0.2469 1.2042 0.1840 0.098*
C6 −0.1622(3) 1.0819(2) 0.1587(2) 0.0666(6)
H6 −0.2144 1.0523 0.0854 0.080*
C7 −0.0763(2) 0.82351(17) −0.00007(16) 0.0475(5)
C8 −0.1439(2) 0.77381(18) −0.11474(16) 0.0485(5)
C9 −0.2518(2) 0.8125(2) −0.18370(18) 0.0624(6)
H9Aa −0.2839 0.7693 −0.2569 0.094*
H9Ba −0.2120 0.8946 −0.1755 0.094*
H9Ca −0.3288 0.7986 −0.1631 0.094*
H9Da −0.2659 0.8724 −0.1401 0.094*
H9Ea −0.3378 0.7471 −0.2215 0.094*
H9Fa −0.2210 0.8431 −0.2339 0.094*
C10 −0.0023(2) 0.67330(17) −0.07684(15) 0.0485(5)
C11 0.2010(2) 0.51194(17) −0.03420(16) 0.0490(5)
H11 0.1660 0.4680 −0.1049 0.059*
C12 0.3068(2) 0.48828(17) 0.04709(15) 0.0463(4)
C13 0.3629(2) 0.53847(17) 0.15536(16) 0.0490(5)
H13 0.3408 0.5958 0.1906 0.059*
C14 0.37430(19) 0.40734(16) 0.03449(16) 0.0453(4)
C15 0.5411(2) 0.51425(17) 0.31162(15) 0.0487(5)
C16 0.5546(3) 0.6107(2) 0.38528(18) 0.0672(6)
H16 0.5083 0.6609 0.3635 0.081*
C17 0.6375(3) 0.6319(2) 0.49149(19) 0.0737(7)
H17 0.6458 0.6966 0.5412 0.088*
C18 0.7076(3) 0.5604(2) 0.52529(19) 0.0681(6)
H18 0.7625 0.5753 0.5973 0.082*
C19 0.6956(3) 0.4658(2) 0.45117(19) 0.0718(7)
H19 0.7443 0.4171 0.4731 0.086*
C20 0.6123(2) 0.4419(2) 0.34454(18) 0.0631(6)
H20 0.6043 0.3772 0.2951 0.076*
C21 0.36078(19) 0.33054(17) −0.06326(15) 0.0457(4)
C22 0.4233(2) 0.24948(17) −0.07495(15) 0.0468(4)
C23 0.5108(3) 0.2049(2) 0.00457(18) 0.0662(6)
H23A 0.4978 0.1258 −0.0282 0.099*
H23B 0.4839 0.2069 0.0635 0.099*
H23C 0.6071 0.2532 0.0298 0.099*
C24 0.4159(2) 0.12852(17) −0.24312(15) 0.0476(5)
C25 0.3142(2) 0.0480(2) −0.33609(18) 0.0630(6)
H25 0.2229 0.0463 −0.3592 0.076*
C26 0.3487(3) −0.0301(2) −0.39476(19) 0.0698(7)
H26 0.2795 −0.0842 −0.4577 0.084*
C27 0.4826(2) −0.03030(19) −0.36294(18) 0.0583(5)
C28 0.5833(2) 0.0531(2) −0.27103(18) 0.0615(6)
H28 0.6749 0.0557 −0.2487 0.074*
C29 0.5518(2) 0.13316(18) −0.21107(17) 0.0571(5)
H29 0.6216 0.1895 −0.1498 0.069*
C30 0.5189(3) −0.1182(2) −0.4260(2) 0.0829(8)
H30A 0.5018 −0.1887 −0.4045 0.124*
Table 2 (continued)
Atom x y z Uiso*/Ueq
H30B 0.6157 −0.0862 −0.4130 0.124*
H30C 0.4625 −0.1356 −0.5007 0.124*
C31 0.0442(3) 0.7709(3) 0.33095(18) 0.0695(7)
H31 −0.0298 0.7803 0.3457 0.083*
C32 −0.0335(3) 0.5739(3) 0.3463(2) 0.0951(10)
H32A −0.1088 0.5959 0.3525 0.143*
H32B 0.0158 0.5575 0.4106 0.143*
H32C −0.0702 0.5053 0.2870 0.143*
C33 0.1734(3) 0.6491(2) 0.3047(2) 0.0761(7)
H33Aa 0.1720 0.5717 0.3068 0.114*
H33Ba 0.2613 0.7056 0.3561 0.114*
H33Ca 0.1610 0.6565 0.2347 0.114*
H33Da 0.2242 0.7175 0.2916 0.114*
H33Ea 0.1349 0.5836 0.2423 0.114*
H33Fa 0.2352 0.6327 0.3637 0.114*
N1 −0.04007(18) 0.94500(15) 0.15474(14) 0.0557(4)
H1 0.0180 0.9157 0.1892 0.067*
N2 −0.10621(17) 0.90385(14) 0.04845(14) 0.0508(4)
N3 −0.10567(18) 0.69380(15) −0.15508(13) 0.0521(4)
N4 0.05193(19) 0.59882(15) −0.10045(13) 0.0553(4)
N5 0.15491(18) 0.59240(15) −0.01024(13) 0.0538(4)
N6 0.45562(17) 0.48988(14) 0.20142(13) 0.0474(4)
N7 0.46462(17) 0.40833(14) 0.12807(13) 0.0490(4)
N8 0.28262(18) 0.33496(16) −0.16124(13) 0.0548(4)
N9 0.29397(18) 0.26183(16) −0.23395(14) 0.0565(4)
N10 0.38006(16) 0.20960(14) −0.18214(13) 0.0471(4)
N11 0.06142(19) 0.66921(19) 0.32940(15) 0.0652(5)
O1 0.11801(19) 0.85403(16) 0.31449(14) 0.0779(5)
S1 0.04514(5) 0.75770(5) 0.05506(4) 0.05228(16)
F1 −0.1233(2) 1.30448(15) 0.38122(16) 0.1219(7)
aOccupancy: 0.5.
ring systems are versatile scaffolds in organic synthesis and
medicinal chemistry due to their biological activities [8–10].
1,2,3-Triazole connected to other heterocycles can be synthe-
sized from reactions of 1,3-diketones, activated alkenes, and
alkynes with nitrogen containing reagents [11]. The synthesis
of pyrazoles can be achieved by performing a condensa-
tion of hydrazines and unsaturated carbonyl containing
compounds [11], whereas thiazoles can be efficiently syn-
thesized through various reactions such Gabriel, Hantzsch
and Cook–Heilborn’s syntheses [12]. Recently, the X-ray crys-
tal structures for related heterocycles have been reported
[13–16].
The asymmetric unit of the structure consists of a
molecule of the title compound, C30H25FN10S, and amolecule
of dimethylformamide solvent (see the figure). The molecule
of the title compound comprises fluorophenyl (A(C1—
C6,F1), methylthiazolyl (B(C7—C10,N3,S1), pyrazolyl (C(C12—
C14,N6,N7), phenyl (D(C15—C20), methyltriazolyl (E(C21—
C23,N8-N10) and methylphenyl (F(C24—C30) rings. In the
molecule, rings A, B, C, D and E are almost coplanar with
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twist anglesA/B= 4.17(13)°,B/C= 1.24(14)°,C/D= 11.59(15)°,
C/E= 7.91(14)°. The plane of the methylphenyl group F
deviates from the plane of the rest of themoleculewith a twist
angle E/F= 43.78(8)°. In the crystal, the planar segments of
the molecules are arranged in layers parallel to the (11-1)
plane. Hydrogen bonding (N1—H11· · ·N8) occurs between
the title molecule and the dimethylformamide solvent. For a
pair of adjacent molecules related by inversion symmetry, the
N=N bonds of the azo groups are parallel with a separation
distance of 3.706 Å and the thiazolyl B and pyrazolyl C rings
of the samemolecules are parallel with a centroid-to-centroid
separation of 3.613 Å. The phenyl groups D of neighbouring
molecules are parallel with a centroid-to-centroid separation
of 4.126 Å.
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